Structural Impact Assessment of Cytochrome P450 2A13 Polymorphisms Using Molecular Dynamics Simulations-Reference-Cited by-同舟云学术

Structural Impact Assessment of Cytochrome P450 2A13 Polymorphisms Using Molecular Dynamics Simulations

Published:2024-03-13 Issue:3 Volume:47 Page:620-628
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Kato Koichi¹²,Nakayoshi Tomoki¹³,Hioki Sho¹,Hiratsuka Masahiro⁴⁵⁶⁷,Ishikawa Yoshinobu²,Kurimoto Eiji¹,Oda Akifumi¹⁸

Affiliation:

1. Faculty of Pharmacy, Meijo University

2. Faculty of Pharmaceutical Sciences, Shonan University of Medical Sciences

3. Graduate School of Information Sciences, Hiroshima City University

4. Graduate School of Pharmaceutical Sciences, Tohoku University

5. Tohoku Medical Megabank Organization, Tohoku University

6. Advanced Research Center for Innovations in Next-Generation Medicine, Tohoku University

7. Department of Pharmaceutical Sciences, Tohoku University Hospital

8. Institute for Protein Research, Osaka University

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/3/47_b23-00908/_pdf

Reference32 articles.

1. 1) Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, Ding X. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res., 60, 5074–5079 (2000).

2. 2) von Weymarn LB, Murphy SE. CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6. Xenobiotica, 33, 73–81 (2003).

3. 3) Bao Z, He XY, Ding X, Prabhu S, Hong JY. Metabolism of nicotine and cotinine by human cytochrome P450 2A13. Drug Metab. Dispos., 33, 258–261 (2005).

4. 4) Murphy SE, Raulinaitis V, Brown KM. Nicotine 5′-oxidation and methyl oxidation by P450 2A enzymes. Drug Metab. Dispos., 33, 1166–1173 (2005).

5. 5) Guo Y, Zhu LR, Lu G, Wang H, Hong JY. Selective expression of CYP2A13 in human pancreatic α-islet cells. Drug Metab. Dispos., 40, 1878–1882 (2012).